Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Supplemental Biologics License Application for Opdivo® Plus Yervoy® for Patients with Unresectable or Metastatic Microsatellite Ins
-
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
-
Kaspi.kz 4Q and FY 2024 Financial Results
-
MAG Provides Exploration Update and Outlook for Larder and Deer Trail Projects
-
Wallbox Announces $10 Million Investment
-
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
-
Bright Minds Biosciences to Participate at Three Healthcare Conferences in March
-
IFS appoints Matt Breslin as President, North America
-
Target Hospitality Provides Update on Pecos Children's Center Contract
-
Canada Nickel Closes Previously Announced Definitive Agreement for Creation of 'ExploreCo' with Spin-out of Eastern Exploration Properties
-
Gold Royalty Announces Amended and Upsized Revolving Credit Facility to Maximum $75 Million at Reduced Interest Cost and Extended Maturity and Provides an Update on Selected Portfolio Assets
-
Merck to Participate in the TD Cowen 45th Annual Health Care Conference
-
Brown & Brown, Inc. names Stephen P. Hearn as executive vice president and chief operating officer
-
BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025
-
Brown & Brown, Inc. names Stephen P. Hearn as executive vice president and chief operating officer
-
Buyback of Class B shares in Essity during week 8, 2025
-
Studio City Announces Earnings Release Date
-
Melco Announces Earnings Release Date
-
Net Asset Value(s)
-
DUBAI GAMES 2025: Montreal and Colorado Clinch the Battle of the Cities Crown
-
Phoenix Motor Surpasses 60 million Zero-Emission Miles Driven
-
Meridian Drills Multiple High-Grade Intercepts at Cabaçal Including 20.9m @ 6.5g/t AuEq (4.4% CuEq)
-
Purepoint Uranium Reports Results from Tabbernor Project Geophysical Survey
-
AZZ Inc. to Participate in the 17th Annual Evercore ISI Industrial Conference and the 37th Annual Roth Conference
-
Westlake Corporation Reports Fourth Quarter and Full Year 2024 Results
-
Veri Medtech (VRHI) Reaches 1.3 million Patient Registrations
-
CampDoc and Traction Rec Partnership Elevates Community-Based Programs
-
Westlake Chemical Partners LP Announces Fourth Quarter and Full Year 2024 Results
-
A.I.S. Resources Announces Private Placement Financing, Shares for Debt Transaction and Appoints Marc Enright-Morin as President and Chief Executive Officer
-
MAC Copper Limited Announces 2024 Resource and Reserve Statement and Production Guidance
-
Zura Bio to Present at the Leerink Partners Global Healthcare Conference
-
Azimut Announces Results of the Annual General Meeting
-
Hyperscale Data Engages Northland Capital Markets to Explore Strategic Options for Michigan Data Center
-
Cycurion (NASDAQ: CYCU) Expands Cybersecurity Partnership with Leading National Public Health Association
-
Issue of Equity
-
Bitget Lists Zoo Adding it to Spot Trading
-
Piraeus FY 2024 Earnings & Business Plan 2025-2028
-
Bitget Announces Pre-Market Trading for Memhash (MEMHASH)
-
ChartUp Launches Innovative Solana Volume Booster Bot
-
Bitget Introduces Bank Deposits with Callpay Integration, Enabling ZAR Access for South African Users
-
ZTE again makes prestigious CDP A List for leading climate action, reinforcing global climate leadership
-
Fresh Del Monte Produce Inc. Reports Fourth Quarter and Full Fiscal Year 2024 Financial Results
-
Brookdale to Present at Citi's 30th Annual Global Property CEO Conference and Barclays 27th Annual Global Healthcare Conference
-
Political Shake-Up Threatens Federal Workforce
-
Bluevine Survey Shows US Small Businesses Confidence is Surging
-
Viablife Achieves U.S. FDA No Objection for Highly-Scalable Biosynthesized Hydroxytyrosol in Collaboration with REJIMUS, INC.
-
Rollbacks vs. Workplace Reality: 88% Say DEI Efforts Have Tangibly Improved Diversity
-
Domino's Pizza® Announces Fourth Quarter and Fiscal 2024 Financial Results
-
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Twelve Months Ended December 31, 2024
-
Beyond, Inc. Closes on the Purchase of Buy Buy Baby
